Patient Handling Equipment Market And its Growth prospect in the Near Future

The global patient handling equipment market is growing at a significant rate due to increasing healthcare expenditure, increasing risk of injuries to caregivers during patient handling and growing geriatric population. The increasing prevalence of chronic diseases and advancements in technology has led to the development of easy to handle and powered patient handling equipment. And the improving healthcare infrastructure in developing countries are also driving the growth of the global patient handling equipment market.

 

Patient handling equipment are equipment used for safely moving or supporting a patient or any of his body part. The equipment improves working conditions of caregivers by reducing biomechanical overload risk, work-related injury and requires high amount of care and skill technique. In addition, the equipment improves quality of patient care and account for patient safety. The factors such as lack of training provided to caregivers for efficient operation of equipment and difficulty in handling bariatric patients are inhibiting the growth of the global market.

 

Request for a sample of this research report: https://www.psmarketresearch.com/market-analysis/patient-handling-equipment-market/report-sample

 

Geographically, Europe dominated the global market of patient handling equipment in 2015; whereas the North American market is expected to witness the fastest growth, a CAGR of 11.0% during the forecast period. This is due to the high awareness among caregivers for safe patient handling and stringent regulations in the region.

 

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=patient-handling-equipment-market

 

Some of the key companies operating in the global patient handling equipment market include Stryker Corporation, Hill-Rom Holdings Inc., Invacare Corporation, Getinge Group, Prism Medical Ltd., Guldmann Inc., LINET Group SE, Joerns Healthcare LLC, Stiegelmeyer-Group, and Handicare.

MRI Compatible Patient Monitoring System Market Trends, Drivers, Growth Opportunities

The global MRI compatible patient monitoring systems market is growing, due to increasing installation of MRI devices. The increase in geriatric population worldwide is resulting in the growth of the global MRI compatible patient monitoring systems market, as the geriatric population is more susceptible to diseases, sickness and syndromes, due to less regenerative abilities.

According to a United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of individuals aged 60 years or above is growing at a very high rate. In addition, with the increase in chronic disease cases, accurate diagnosis is needed for the prevention and treatment of such diseases; thus leading to increased usage of MRI scans for the diagnosis of chronic diseases. Moreover, the increase in prevalence of chronic diseases is likely to increase the demand for monitoring during scan, which is leading to increased demand for MRI compatible patient monitoring systems.

The information and data in the publication “Global MRI Compatible Patient Monitoring Systems Market Size, Share, Development, Growth and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondary sources. The top-bottom approach has been used to calculate the global MRI compatible patient monitoring systems market. P&S Intelligence analysts and consultants interact with leading companies of the concerned domain to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Download Sample of This Research Report:  https://www.psmarketresearch.com/market-analysis/magnetic-resonance-imaging-compatible-patient-monitoring-system-market/report-sample

 

However, certain restraints including strict regulatory requirements for the approval of MRI compatible patient monitoring systems, and high cost of MRI compatible patient monitoring systems are hindering the growth of the global MRI compatible patient monitoring market. The increasing awareness about MRI compatible patient monitoring systems in developing countries, such as China and India, are laying opportunities for the growth of the global MRI compatible patient monitoring systems market. North America dominates the global MRI compatible patient monitoring systems market, due to the presence of developed healthcare infrastructure, high healthcare spending and increasing prevalence of chronic diseases. According to the Organization for Economic Co-operation and Development (OECD), in 2001, the number of MRI units per 1 million inhabitants in Canada and the U.S. were 4.19 and 20.11 respectively, which increased to 8.83 and 35.49 respectively, in 2013.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=magnetic-resonance-imaging-compatible-patient-monitoring-system-market

Europe is witnessing growth in MRI compatible patient monitoring systems market, which is attributed to increasing geriatric population, high incidences of chronic diseases and growing awareness among healthcare providers for the usage of MRI compatible patient monitoring systems. According to the European Society of Cardiology, a non-profit health association, each year four million people die in Europe due to cardiovascular diseases, which is responsible for 47% death toll in the region.

Similarly, the Asia-Pacific MRI compatible patient monitoring systems market is expected to grow at the fastest rate during the period 2015 – 2020. According to the OECD, in 2002, the number of MRI units per million inhabitants in Japan was 35.32, which increased to 46.87 in 2011.

Insulin Delivery Device Market Application and Product Type

The increasing prevalence of diabetes, growing geriatric population, increasing prevalence of obesity, technological of drug delivery devices and increasing awareness of diabetic care are driving the growth of the market.

Request for a sample of this research report: https://www.psmarketresearch.com/market-analysis/insulin-delivery-devices/report-sample

Various initiatives, such as programs, activities and campaigns, are implemented by IDF, NGOs, diabetes associations and health departments to create awareness among people regarding effects of diabetes and correct method of treatment is driving the growth of the insulin delivery device market. One such example is a major initiative taken at a global level in the form of World Diabetes Day; celebrated on 14th November each year. World Diabetes Day is a key campaign led by IDF and its member associations, such as the (American Diabetes Association) ADA, Diabetes UK, Diabetes Australia, Diabetes South Africa, the Canadian Diabetes Association (CDA), Diabetes New Zealand, and Diabetic Association of India.

Insulin pen needle has single use, although many diabetic patients re-use needle for delivery of insulin. The re-use of needle could lead to bacterial growth on the needle, risk of lipohypertrophy and risk of breaking fine tip of needle. Similarly, the risk associated with jet injectors are accuracy of insulin dosage and improper injection. Improper injection of insulin can lead to altered absorption level of insulin in the blood stream and bruising. Hence, these risks and complications associated with delivery devices are inhibiting the growth of the insulin delivery device market.

Some of the key companies operating in the insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.

Diagnostic Imaging Systems Market Top Leading Companies and Industry Outlook

The X-ray imaging systems category dominated the global market and generated revenue worth $15.2 billion in 2018, which is projected to reach $20.5 billion by 2024, progressing at a CAGR of 5.2% during the forecast period (2019–2024). Besides, the industry witnessed fastest growth in the category of nuclear imaging systems. The growth of this category is mainly driven by increasing prevalence of cancer, and rising demand for these systems across the globe. Furthermore, the market size for ultrasound systems, which stood at $5.9 billion in 2018, is expected to reach $8.3 billion by 2024, witnessing a CAGR of 6.0% during the forecast period.

Download Sample Copy :  https://www.psmarketresearch.com/market-analysis/diagnostic-imaging-systems-market/report-sample

Globally, North America and Europe, will together account for over 60% share in the diagnostic imaging systems market by 2024. This can be mainly attributed to the presence of established players, increasing adoption of telemedicine, and increase in prevalence of chronic diseases in these regions.

APAC, LATAM, and MEA also hold considerable shares in the global diagnostic imaging systems market, on account of the technological advancements, surging geriatric population, rising prevalence of chronic diseases, increasing healthcare expenditure, and rising awareness about early detection of diseases in these regions.

In January 2019, the U.S. Food and Drug Administration (USFDA) approved Siemens Healthineers’s MAGNETOM Lumina 3 Tesla MRI scanner. The system features BioMatrix patient personalization technology, which significantly improves productivity while reducing scan time. Furthermore, in September 2018, Carestream Health Inc. received the USFDA 510(k) Clearance for its OnSight 3D Extremity System. This imaging system uses cone beam CT technology to capture weight-bearing and other types of extremity exams.

Other prominent players in the diagnostic imaging systems market include Konica Minolta Inc., Dornier MedTech GmbH, SternMed GmbH, MinFound Medical Systems Co. Ltd., DRGEM CO. LTD., SonoScape Medical Corporation, Analogic Corporation, and Fonar Corporation.

Beauty Devices Market Comprehensive Review of its Growth Opportunities and Demand

The market is mainly driven by the rising incidence of skin diseases, surging disposable income, escalating geriatric population, increasing appearance consciousness and awareness about beauty devices, and growing prevalence of hormonal disorders, according to P&S Market Research.

In terms of usage, the beauty devices market has been categorized into salon, spa, at-home, and others. During the forecast period, the market is expected to witness the highest growth in the at-home category, with a CAGR of 20.2%. The easy availability of these beauty devices across the globe and less expertise required for their use leads to their increased adoption is attributing to its growing popularity globally.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/beauty-devices-market/report-sample

During the forecast period, the European beauty devices industry is expected to outpace the North American beauty devices industry, in terms of growth, on account of increasing healthcare spending, growing aging population, increasing prevalence of skin diseases, and technological advancements in beauty devices.

Pre-Purchase Enquiry:  https://www.psmarketresearch.com/send-enquiry?enquiry-url=beauty-devices-market

According to the European Commission publication in 2014, the population of people aged 65 years and above was approximately 93.2 million in 2013, and the number is estimated to reach 105.3 million by 2020. The aging population is driving the demand of beauty devices, as aging leads to skin dryness, which further leads to the formation of wrinkles. This happens due to the weakening of collagen, the protein that provides strength and elasticity to the skin. Certain beauty devices help in building collagen to reveal a younger looking skin; thereby leading to the growth of the market.

Some of the other key players operating in the beauty devices market are Panasonic Corporation, Lumenis Ltd, Home Skinovations Ltd, the Procter & Gamble Company, Syneron Medical Ltd, iluminage Beauty Inc., Koninklijke Philips N.V., and Carol Cole Company.